Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 September 2023

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 60 Renminbi (CNY) 17 Euro (EUR) 12 Indian rupee (INR) 5 Other currencies (CAD, DKK, GBP, HDK, SEK) 4 Swiss franc (CHF) 2 #d997b6 #cc5d3f #60504c #49753d #b7d4d8 #cab415 #423e3d #3880c0 #ad2d3c #94743a
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Private companies 39 Public (from private) companies 24 Public companies 20 Funds 10 Cash and cash equivalents 5 Other assets 2 #d997b6 #cc5d3f #60504c #49753d #b7d4d8 #cab415 #423e3d #3880c0 #ad2d3c #94743a
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 40 Products on the market 27 Preclinical 7 Phase I 8 Phase II 13 Phase III 5 #d997b6 #cc5d3f #60504c #49753d #b7d4d8 #cab415 #423e3d #3880c0 #ad2d3c #94743a
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 24 Oncology 17 Synthetic biology 17 Central nervous system 11 Digital Health 11 Orphan diseases 8 Immunology/Inflammation 7 Medical technology / diagnostics 5 #d997b6 #cc5d3f #60504c #49753d #b7d4d8 #cab415 #423e3d #3880c0 #ad2d3c #94743a